David Roman

Stock Analyst at Goldman Sachs

(1.56)
# 2,280
Out of 4,479 analysts
11
Total ratings
100%
Success rate
5.44%
Average return

11 Stocks

Boston Scientific
May 30, 2024
Initiates: Buy
Price Target: $90
Current: $76.55
Upside: +17.57%
Edwards Lifesciences
May 30, 2024
Initiates: Buy
Price Target: $107
Current: $91.23
Upside: +17.29%
Stryker
May 30, 2024
Initiates: Neutral
Price Target: $372
Current: $334.30
Upside: +11.28%
Intuitive Surgical
May 30, 2024
Initiates: Buy
Price Target: $500
Current: $438.81
Upside: +13.94%
Abbott Laboratories
May 30, 2024
Initiates: Buy
Price Target: $121
Current: $103.20
Upside: +17.25%
Becton, Dickinson and Company
May 30, 2024
Initiates: Buy
Price Target: $274
Current: $229.24
Upside: +19.53%
Baxter International
May 30, 2024
Initiates: Neutral
Price Target: $36
Current: $32.85
Upside: +9.59%
Solventum
May 30, 2024
Initiates: Sell
Price Target: $54
Current: $51.60
Upside: +4.65%
Zimmer Biomet Holdings
May 30, 2024
Initiates: Neutral
Price Target: $129
Current: $106.27
Upside: +21.39%
Medtronic
May 30, 2024
Initiates: Sell
Price Target: $83
Current: $77.37
Upside: +7.28%
GE HealthCare Technologies
May 30, 2024
Initiates: Neutral
Price Target: $87
Current: $76.33
Upside: +13.98%